NEWTON, Mass.--(BUSINESS WIRE)--March 10, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate-based therapeutic compounds, today reported its unaudited fourth quarter and full year 2005 financial results, ended December 31, 2005.
